Literature DB >> 15200425

Differential effects of simvastatin on mesangial cells.

Juliane Heusinger-Ribeiro1, Barbara Fischer, Margarete Goppelt-Struebe.   

Abstract

BACKGROUND: Statins are increasingly recognized as mediators of direct cellular effects independent of their lipid lowering capacity. Therefore, the time and concentration dependence of various statin-mediated cellular alterations was compared in renal mesangial cells.
METHODS: The effects of statins on cell proliferation, gene expression, cytoskeletal alterations, apoptosis, and cytotoxicity were analyzed in cultured mesangial cells using standard techniques.
RESULTS: Simvastatin and lovastatin decreased proliferation and cell number of rat mesangial cells concentration-dependently. Concurrently, the expression of the fibrogenic protein connective tissue growth factor (CTGF) was impaired and actin stress fibers, which are typical of mesangial cells in culture, became disassembled by simvastatin. A decrease of the posttranslational modification of RhoA by geranylgeranyl moieties was detected, supporting a role for RhoA as mediator of statin effects. Induction of apoptosis, determined by activation of caspase-3 and DNA fragmentation, and necrosis only occurred at later time points, when the morphology of the cells was strongly altered and the cells detached from the surface due to changes in the actin cytoskeleton. Basically, the same results were obtained with a human mesangial cell line. Furthermore, statin effects were mimicked by inhibition of the geranylgeranyltransferase.
CONCLUSION: Most of the cellular effects of the lipophilic statins occurred within the same time and concentration range, suggesting a common molecular mechanism. Only apoptosis and necrosis were observed at later time points or with higher concentrations of simvastatin and thus seem to be secondary to the changes in gene expression and alterations of the actin cytoskeleton.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15200425     DOI: 10.1111/j.1523-1755.2004.00710.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  8 in total

Review 1.  The role of connective tissue growth factor (CTGF/CCN2) in skeletogenesis.

Authors:  John A Arnott; Alex G Lambi; Christina Mundy; Honey Hendesi; Robin A Pixley; Thomas A Owen; Fayez F Safadi; Steven N Popoff
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2011       Impact factor: 1.807

2.  Simvastatin induces apoptosis and alters cytoskeleton in endometrial stromal cells.

Authors:  Anna Sokalska; Donna H Wong; Amanda Cress; Piotr C Piotrowski; Izabela Rzepczynska; Jesus Villanueva; Antoni J Duleba
Journal:  J Clin Endocrinol Metab       Date:  2010-04-28       Impact factor: 5.958

3.  Simvastatin decreases invasiveness of human endometrial stromal cells.

Authors:  Anna Sokalska; Amanda Cress; Kaylon L Bruner-Tran; Kevin G Osteen; Hugh S Taylor; Israel Ortega; Antoni J Duleba
Journal:  Biol Reprod       Date:  2012-07-05       Impact factor: 4.285

4.  High ambient glucose augments angiotensin II-induced proinflammatory gene mRNA expression in human mesangial cells: effects of valsartan and simvastatin.

Authors:  Masayo Naito; Ananth Shenoy; Isao Aoyama; Joseph S Koopmeiners; Radko Komers; H William Schnaper; Karol Bomsztyk
Journal:  Am J Nephrol       Date:  2009-02-19       Impact factor: 3.754

5.  Renoprotection by statins is linked to a decrease in renal oxidative stress, TGF-beta, and fibronectin with concomitant increase in nitric oxide bioavailability.

Authors:  Ming-Sheng Zhou; Ivonne Hernandez Schuman; Edgar A Jaimes; Leopoldo Raij
Journal:  Am J Physiol Renal Physiol       Date:  2008-05-07

6.  The effect of statin on epithelial-mesenchymal transition in peritoneal mesothelial cells.

Authors:  Tae Ik Chang; Hye-Young Kang; Kyung Sik Kim; Sun Ha Lee; Bo Young Nam; Jisun Paeng; Seonghun Kim; Jung Tak Park; Tae-Hyun Yoo; Shin-Wook Kang; Seung Hyeok Han
Journal:  PLoS One       Date:  2014-10-02       Impact factor: 3.240

7.  Simvastatin modulates cellular components in influenza A virus-infected cells.

Authors:  Parvaneh Mehrbod; Mohd Hair-Bejo; Tengku Azmi Tengku Ibrahim; Abdul Rahman Omar; Mohamed El Zowalaty; Zahra Ajdari; Aini Ideris
Journal:  Int J Mol Med       Date:  2014-04-28       Impact factor: 4.101

8.  Strategies for blocking the fibrogenic actions of connective tissue growth factor (CCN2): From pharmacological inhibition in vitro to targeted siRNA therapy in vivo.

Authors:  David R Brigstock
Journal:  J Cell Commun Signal       Date:  2009-03-18       Impact factor: 5.782

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.